CA2252983C - Method for determining the anticoagulatory potential of a sample - Google Patents

Method for determining the anticoagulatory potential of a sample Download PDF

Info

Publication number
CA2252983C
CA2252983C CA2252983A CA2252983A CA2252983C CA 2252983 C CA2252983 C CA 2252983C CA 2252983 A CA2252983 A CA 2252983A CA 2252983 A CA2252983 A CA 2252983A CA 2252983 C CA2252983 C CA 2252983C
Authority
CA
Canada
Prior art keywords
thrombomodulin
protein
thrombin
sample
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2252983A
Other languages
English (en)
French (fr)
Other versions
CA2252983A1 (en
Inventor
Michael Kraus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Products GmbH
Original Assignee
Siemens Healthcare Diagnostics Products GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Products GmbH filed Critical Siemens Healthcare Diagnostics Products GmbH
Publication of CA2252983A1 publication Critical patent/CA2252983A1/en
Application granted granted Critical
Publication of CA2252983C publication Critical patent/CA2252983C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7452—Thrombomodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2252983A 1997-11-07 1998-11-06 Method for determining the anticoagulatory potential of a sample Expired - Fee Related CA2252983C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19749197.9 1997-11-07
DE19749197A DE19749197A1 (de) 1997-11-07 1997-11-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe

Publications (2)

Publication Number Publication Date
CA2252983A1 CA2252983A1 (en) 1999-05-07
CA2252983C true CA2252983C (en) 2010-07-13

Family

ID=7847900

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2252983A Expired - Fee Related CA2252983C (en) 1997-11-07 1998-11-06 Method for determining the anticoagulatory potential of a sample

Country Status (8)

Country Link
US (2) US20020019021A1 (enExample)
EP (1) EP0915340B1 (enExample)
JP (1) JP4361980B2 (enExample)
AT (1) ATE315233T1 (enExample)
AU (1) AU751525B2 (enExample)
CA (1) CA2252983C (enExample)
DE (2) DE19749197A1 (enExample)
ES (1) ES2255121T3 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0947585T3 (da) * 1998-03-19 2001-10-01 Instrumentation Lab Spa Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter
WO2001098782A1 (fr) * 2000-06-22 2001-12-27 Mochida Pharmaceutical Co., Ltd Kit de determination du pouvoir de coagulation du sang
US6432658B1 (en) * 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
US6448024B1 (en) 2000-10-03 2002-09-10 Roche Diagnostics Corporation Method, reagent, cartridge, and device for determining fibrinogen
US6743596B1 (en) 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6645768B1 (en) 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
EP1367135A1 (en) * 2002-05-29 2003-12-03 Pentapharm AG Improved method for the assessment of thrombin formation in blood or plasma
WO2005031303A2 (en) * 2003-09-22 2005-04-07 University Of North Carolina At Chapel Hill Soluble phospholipids for use in clotting factor assays
US20050221414A1 (en) * 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
WO2006088741A2 (en) * 2005-02-16 2006-08-24 The Board Of Trustees Of The University Of Illinois Procoagulants based on metal-chelating lipids
EP1869082B1 (en) * 2005-03-04 2011-04-13 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
JP2009198506A (ja) * 2009-04-10 2009-09-03 Shino Test Corp 血液凝固反応抑制血漿タンパク質の活性測定方法及び活性測定試薬
EP2619540B1 (en) * 2010-09-20 2018-03-21 Q-Sera Pty Ltd Serum preparation
JP5818299B2 (ja) * 2010-12-27 2015-11-18 国立大学法人名古屋大学 凝固因子として作用する異常トロンビンのためのトロンビン不活化動態測定方法
CN103688177B (zh) * 2011-06-17 2017-07-04 学校法人东日本学园 狼疮抗凝物检测用血液凝固时间的测定方法
WO2014020183A1 (de) 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh In-vitro-assay zur diagnose von störungen der hämostase
CN104374621A (zh) * 2014-11-03 2015-02-25 温州市倍可特医疗器械有限公司 用于血液采集容器的血液促凝剂及其制备方法和应用
WO2016172291A1 (en) * 2015-04-23 2016-10-27 Fermi Research Alliance, Llc Monocrystal-based microchannel plate image intensifier
JP7170714B2 (ja) 2018-04-04 2022-11-14 三菱電機株式会社 赤外線固体撮像装置
EP4269605A4 (en) * 2020-12-28 2024-11-20 Fujimori Kogyo Co., Ltd. BLOOD COAGULATION INSPECTION PROCEDURES
CN115219292B (zh) * 2022-06-09 2025-09-30 常熟常江生物技术有限公司 全自动血栓弹力图仪质控品及其制备方法、应用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221614A (en) * 1988-03-03 1993-06-22 Nippon Shoji Kabushiki Kaisha Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
AU6403590A (en) * 1989-09-25 1991-04-18 Asahi Kasei Kogyo Kabushiki Kaisha Isolated, physiologically active human thrombomodulin polypeptide
ES2170747T3 (es) * 1990-08-15 2002-08-16 Paion Gmbh Analogos superiores de trombomodulina para uso farmaceutico.
IL100093A0 (en) * 1990-11-30 1992-08-18 Kowa Co Thrombin-binding substance and process for preparing the same
US5273962A (en) * 1990-11-30 1993-12-28 Kowa Co., Ltd. Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
FR2689640B1 (fr) * 1992-04-06 1997-08-08 Bio Merieux Procede pour la determination d'une activite proteine c et/ou proteine s dans un echantillon plasmatique.
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
DE4427785A1 (de) * 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
EP0711838B2 (de) * 1994-11-10 2007-06-20 Dade Behring Marburg GmbH Verfahren zum spezifischen Nachweis eines aktivierten Gerinnungsfaktors V mit einer erhöhten Stabilität gegenüber aktiviertem Protein C

Also Published As

Publication number Publication date
US20020019021A1 (en) 2002-02-14
EP0915340B1 (de) 2006-01-04
AU751525B2 (en) 2002-08-22
CA2252983A1 (en) 1999-05-07
JPH11225796A (ja) 1999-08-24
DE19749197A1 (de) 1999-05-12
ATE315233T1 (de) 2006-02-15
EP0915340A1 (de) 1999-05-12
US20030207343A1 (en) 2003-11-06
ES2255121T3 (es) 2006-06-16
AU9139798A (en) 1999-05-27
DE59813326D1 (de) 2006-03-30
JP4361980B2 (ja) 2009-11-11

Similar Documents

Publication Publication Date Title
CA2252983C (en) Method for determining the anticoagulatory potential of a sample
US5051357A (en) Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
JP3047120B2 (ja) 活性化因子ｖｉｉに関する定量的凝血検定
US5525478A (en) Soluble thrombomodulin-based one-stage assay for vitamin-K dependent coagulation-inhibiting proteins
US5443960A (en) Method for the diagnosis of blood coagulation disorders
US6994984B2 (en) Hematological assay
Bergström et al. Determination of vitamin K sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substrates
US20030064414A1 (en) Rapid assessment of coagulation activity in whole blood
Jesty The kinetics of inhibition of alpha-thrombin in human plasma.
JPH11225796A5 (enExample)
CA2333890A1 (en) Corn trysin inhibitor stabilizes blood-derived plasma and improves sensitivity of plasma clotting assays
US5780255A (en) Protein C pathway screening test
JP3533012B2 (ja) プロテインｃ／プロテインｓ系の障害を検出する方法
Fareed et al. Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
US5643739A (en) Assay for determining sensitivity to activated protein C
US5753510A (en) Calibrator for use in test methods for detecting a defective coagulation factor V
Fareed et al. Synthetic peptide substrates in hemostatic testing
CA2421957C (en) Method for measuring antithrombin activity
Hoppensteadt et al. Validity of serine protease inhibition tests in the evaluation and monitoring of the effect of heparin and its fractions
US5200322A (en) Method for assaying protein C and measuring kit for the same
KR100452014B1 (ko) 안티트롬빈iii-함유용액중의글리코스아미노글리칸을정량하는방법
JP4331891B2 (ja) 改良された血液凝固試験法
HU219457B (hu) Meizotrombint, meizotrombin(des F1)-t vagy keverékeiket tartalmazó reagens, valamint tesztkészlet diagnosztikai célokra
EP0260707A2 (en) Method for assaying plasma protein and measuring kit for the same
CA2598757A1 (en) Method for determining the total coagulation activity of a blood or plasma sample

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20121106